|
|
|
41
|
17025
|
TRIFLUOPERAZINE 5MG TAB (REM)
|
TRIFLUOPERAZINE
|
TRIFLUOPERAZINE
|
1000'S
|
A
|
55.29
|
0.0553
|
TAB
|
252
|
BOTT
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
28160824
|
PHENOTHIAZINES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PHENOTHIAZINES
|
|
|
|
|
42
|
17025
|
TRIFLUOPERAZINE 5MG TAB (REM)
|
TRIFLUOPERAZINE
|
TRIFLUOPERAZINE
|
1000'S
|
A
|
54.91
|
0.05
|
TAB
|
252
|
BOTT
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
28160824
|
PHENOTHIAZINES
|
2026-04-01
|
|
|
ORAL
|
6
|
PHENOTHIAZINES
|
|
|
|
|
40
|
17026
|
AAP-TRIFLUOPERAZINE 5MG TAB (APO/COL)
|
TRIFLUOPERAZINE
|
AAP-TRIFLUOPERAZINE
|
100'S
|
A
|
6.25
|
0.06
|
TABLET
|
180
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
28160824
|
PHENOTHIAZINES
|
2022-04-01
|
2024-03-31
|
NAME CHANGED TO AAP
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-12-31
|
|
|
|
40
|
17026
|
AAP-TRIFLUOPERAZINE 5MG TAB (APO/COL)
|
TRIFLUOPERAZINE
|
AAP-TRIFLUOPERAZINE
|
100'S
|
A
|
6.25
|
0.0625
|
TABLET IMMED
|
|
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
28160824
|
PHENOTHIAZINES
|
2022-04-01
|
2024-03-31
|
Name Change
|
Oral
|
6
|
PHENOTHIAZINES
|
2023-02-01
|
|
|
|
41
|
17211
|
PMS-METHYLPHENIDATE 10MG TAB (PMS)
|
METHYLPHENIDATE
|
PMS-METHYLPHENIDATE
|
100'S
|
A
|
18.35
|
0.1835
|
TAB
|
84
|
BOTT
|
PMS
|
PHARMASCIENCE
|
COL
|
COLLINS LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
RESPIRATORY-CEREBRAL STIMULANTS
|
|
|
|
|
42
|
17211
|
PMS-METHYLPHENIDATE 10MG TAB (PMS)
|
METHYLPHENIDATE
|
PMS-METHYLPHENIDATE
|
100'S
|
A
|
17.67
|
0.18
|
TAB
|
84
|
BOTT
|
PMS
|
PHARMASCIENCE
|
COL
|
AVENTA BARBADOS
|
|
282032
|
RESPIRATORY-CNS STIMULANTS
|
2026-04-01
|
|
|
ORAL
|
6
|
RESPIRATORY-CNS STIMULANTS
|
|
|
|
|
40
|
17212
|
APO-METHYLPHENIDATE 10MG TAB (APO/COL)
|
METHYLPHENIDATE
|
APO-METHYLPHENIDATE
|
100'S
|
A
|
19.03
|
0.19
|
TABLET
|
60
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
17212
|
APO-METHYLPHENIDATE 10MG TAB (APO)
|
METHYLPHENIDATE
|
APO-METHYLPHENIDATE
|
100'S
|
A
|
19.41
|
0.19
|
TAB
|
84
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
282032
|
RESPIRATORY-CNS STIMULANTS
|
2026-04-01
|
|
|
ORAL
|
6
|
RESPIRATORY-CNS STIMULANTS
|
|
|
|
|
40
|
17213
|
RITALIN 10MG TAB (NVS/COL) METHYLPHENIDATE
|
METHYLPHENIDATE
|
RITALIN
|
30'S
|
C
|
11.82
|
0.39
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
17213
|
RITALIN 10MG TAB (NVS) METHYLPHENIDATE (C)
|
METHYLPHENIDATE
|
RITALIN
|
30'S
|
C
|
21.12
|
0.704
|
TAB
|
84
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
RESPIRATORY-CEREBRAL STIMULANTS
|
|
|
|
|
42
|
17213
|
RITALIN 10MG TAB (NVS) METHYLPHENIDATE
|
METHYLPHENIDATE
|
RITALIN
|
30'S
|
C
|
17.59
|
0.59
|
TAB
|
84
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
282032
|
RESPIRATORY-CNS STIMULANTS
|
2026-04-01
|
|
|
ORAL
|
6
|
RESPIRATORY-CNS STIMULANTS
|
|
|
|
|
41
|
1721C
|
APO-METHYLPHENIDATE 10MG TAB (APO)
|
METHYLPHENIDATE
|
APO-METHYLPHENIDATE
|
100'S
|
A
|
19.41
|
0.1941
|
TAB
|
84
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
RESPIRATORY-CEREBRAL STIMULANTS
|
|
|
|
|
41
|
17224
|
PMS-METHYLPHENIDATE 20MG TAB (PMS)
|
METHYLPHENIDATE
|
PMS-METHYLPHENIDATE
|
100'S
|
A
|
22.43
|
0.2243
|
TAB
|
90
|
BOTT
|
PMS
|
PHARMASCIENCE
|
COL
|
COLLINS LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
RESPIRATORY-CEREBRAL STIMULANTS
|
|
|
|
|
40
|
17225
|
APO-METHYLPHENIDATE 20MG TAB (APO/COL)
|
METHYLPHENIDATE
|
APO-METHYLPHENIDATE
|
100'S
|
A
|
23.11
|
0.23
|
TABLET
|
90
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
17225
|
APO-METHYLPHENIDATE 20MG TAB (APO)
|
METHYLPHENIDATE
|
APO-METHYLPHENIDATE
|
100'S
|
A
|
23.57
|
0.24
|
TAB
|
90
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
282032
|
RESPIRATORY-CNS STIMULANTS
|
2026-04-01
|
|
|
ORAL
|
6
|
RESPIRATORY-CNS STIMULANTS
|
|
|
|
|
41
|
17228
|
APO-METHYLPHENIDATE 20MG TAB (APO)
|
METHYLPHENIDATE
|
APO-METHYLPHENIDATE
|
100'S
|
A
|
23.57
|
0.2357
|
TAB
|
90
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
RESPIRATORY-CEREBRAL STIMULANTS
|
|
|
|
|
42
|
17229
|
PMS-METHYLPHENIDATE 20MG CAP (PMS)
|
METHYLPHENIDATE
|
PMS-METHYLPHENIDATE
|
100'S
|
A
|
21.75
|
0.22
|
TAB
|
84
|
BOTT
|
PMS
|
PHARMASCIENCE
|
COL
|
AVENTA BARBADOS
|
|
282032
|
RESPIRATORY-CNS STIMULANTS
|
2026-04-01
|
|
|
ORAL
|
6
|
RESPIRATORY-CNS STIMULANTS
|
|
|
|
|
40
|
17231
|
CONCERTA 18MG TAB (JAC/STO) METHYLPHENIDATE
|
METHYLPHENIDATE
|
CONCERTA
|
30'S
|
C
|
130.43
|
4.35
|
TABLET
|
0
|
TAB
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
17231
|
CONCERTA 18MG ER TAB (JAC) METHYLP (C)
|
METHYLPHENIDATE
|
CONCERTA
|
30'S
|
C
|
130.43
|
4.3477
|
TABER
|
42
|
BOTT
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2024-04-01
|
2024-06-20
|
|
ORAL
|
6
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2024-06-18
|
|
|
|
41
|
17231
|
CONCERTA 18MG ER TAB (JAC) METHYLPHENIDATE
|
METHYLPHENIDATE
|
CONCERTA
|
30'S
|
A
|
130.43
|
4.3477
|
TABER
|
30
|
BOTT
|
JAC
|
JANSSEN-CILAG
|
STO
|
BRYDEN STOKES LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2024-06-21
|
2024-07-31
|
|
ORAL
|
6
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2024-06-18
|